FDA Warning Letter: Biosensors Interventional Technologies Pte Ltd
Medical Device Reporting/Misbranded. Issued by FDA OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality on 2023-07-21.
FDA OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality
Biosensors Interventional Technologies Pte Ltd